Circulating Hsp70: a tumor biomarker for lymph node metastases and early relapse in thoracic cancer
In summary, we propose circulating eHsp70 levels before any treatment as a predictive biomarker for the presence of lymph node metastases and early therapy failure in patients with thoracic malignancies.
Authors
- Gabriele Multhoff (ORCID: https://orcid.org/0000-0002-2616-3137)
- Sophie Seier
- Johannes Bodner
- Verena Messner (ORCID: https://orcid.org/0009-0000-0314-2133)
- Seyer Safi (ORCID: https://orcid.org/0000-0002-2335-4309)
- Alan Graham Pockley (ORCID: https://orcid.org/0000-0001-9593-6431)
- Dominik Lobinger (ORCID: https://orcid.org/0000-0001-8442-6380)
- Nicholas Taylor (ORCID: https://orcid.org/0000-0002-6607-7903)
- Ali Bashiri Dezfouli (ORCID: https://orcid.org/0009-0003-1412-5349)
- Erika Roberts
Institutions
- TUM Klinikum (DE)
- München Klinik Bogenhausen (DE)
- Nottingham Trent University (GB)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-08-09
- DOI
- https://doi.org/10.1186/s12885-025-14725-5
- Primary Topic
- Heat shock proteins research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bundesministerium für Bildung und Forschung
- Bayerische Forschungsstiftung
- Technische Universität München